BSNU / Kasr Al Ainy 2025–2026 Obstetrics & Gynecology Exam Prep

OB/GYN Emergency MCQ Rescue Hub

A calm, structured medical learning platform combining 16 Priority A clinical summaries, 80 Progressive MCQs in 10-question sessions, 3 full-length Mock Examinations (130 MCQs), 36 active-recall flashcards, and 6 print-ready A4 PDFs.

Main Study & Examination Modules

Step 1 • Strategy

72-Hour Emergency Study Plan

Forensic exam analysis, Top 15 verbatim repeated concepts, Priority A/B/C triage matrix, and 3-day schedule.

Open 72-Hour Plan โ†’
Obstetrics • O1–O8

Obstetrics High-Yield Summaries

Labor, malpresentations, shoulder dystocia, forceps/vacuum, PPH, inversion, APH, ectopic/mole, preeclampsia & GDM.

Study Obstetrics โ†’
Gynecology • G1–G8

Gynecology High-Yield Summaries

Endometrial, cervical & ovarian oncology, amenorrhea/DSD, PCOS, AUB, fibroids, endometriosis, prolapse & fistula.

Study Gynecology โ†’
8 Sessions × 10 Qs

Progressive MCQ Rescue Bank

80 high-yield MCQs organized into 8 manageable 10-question sessions across Levels 1–4 with 3-step progressive hints.

Practice Unsolved โ†’ Solved Key โ†’
3 Papers • 130 MCQs

Mock Examinations 1, 2 & 3

Independent exam simulations: Mock 1 (50 Combined Qs), Mock 2 (40 Obstetrics Qs), and Mock 3 (40 Gynecology Qs).

Enter Mock Exam Center โ†’
24-Hr Triage • 36 Cards

Final 24-Hour Revision & Flashcards

20 gold-standard cutoffs, FIGO/tumor pathology matrix, master differential tables, algorithms, Top 20 traps & flashcards.

Open 24-Hour Revision โ†’

Independent Component Progress Trackers

Study Materials Library – Download Professional PDFs

Six publication-quality A4 PDFs (247 pages total) formatted for offline reading and printing.

๐Ÿ“ฆ Download All 6 PDFs ZIP (3.09 MB (3,237,990 bytes)) Full Download Center โ†’
A4 PDF 33 Pages • 714.9 KB

OB/GYN 72-Hour Emergency Rescue Plan & High-Yield Clinical Compendium

Complete forensic analysis of past exams, syllabus prioritization matrix (Priority A/B/C), 16 Priority A Obstetrics & Gynecology clinical summaries (G1โ€“G8 & O1โ€“O8), and the 72-hour study schedule.

72-hour-rescue-plan.pdf (714.9 KB (732,103 bytes))
โฌ‡ Download PDF ๐Ÿ‘ Preview
A4 PDF 48 Pages • 1.00 MB

Progressive MCQ Rescue Bank โ€“ SOLVED (80 Questions)

All 80 progressive MCQs across Levels 1โ€“4 with highlighted correct answers, complete clinical explanations, distractor rationales, high-yield takeaways, and the Q74 Editorial Review Note.

progressive-mcqs-solved.pdf (1.00 MB (1,050,199 bytes))
โฌ‡ Download PDF ๐Ÿ‘ Preview
A4 PDF 28 Pages • 602.7 KB

Progressive MCQ Rescue Bank โ€“ UNSOLVED (80 Questions)

Active-recall workbook containing the exact same 80 progressive MCQs in identical order and numbering with zero answers, explanations, or hints revealed, plus a printable self-test answer grid.

progressive-mcqs-unsolved.pdf (602.7 KB (617,182 bytes))
โฌ‡ Download PDF ๐Ÿ‘ Preview
A4 PDF 49 Pages • 991.8 KB

OB/GYN Mock Exams 1, 2 & 3 โ€“ UNSOLVED (130 Questions)

Three full-length exam simulations (Mock 1: 50 Combined MCQs; Mock 2: 40 Obstetrics MCQs; Mock 3: 40 Gynecology MCQs) with provenance tags and blank candidate answer sheets.

mock-exams-unsolved.pdf (991.8 KB (1,015,628 bytes))
โฌ‡ Download PDF ๐Ÿ‘ Preview
A4 PDF 74 Pages • 1.55 MB

OB/GYN Mock Exams 1, 2 & 3 โ€“ SOLVED with Answer Keys and Explanations

Rapid 60-second self-grading answer key grids plus complete solved explanations, distractor breakdowns, textbook page references, and StatPearls citations for all 130 mock exam questions.

mock-exams-solved.pdf (1.55 MB (1,628,079 bytes))
โฌ‡ Download PDF ๐Ÿ‘ Preview
A4 PDF 15 Pages • 437.4 KB

Final 24-Hour Emergency Revision Package

Concentrated last-day revision guide featuring 20 must-memorize numerical cutoffs, FIGO staging, 11-row ovarian tumor matrix, 3 master differential tables, 5 management algorithms, and Top 20 exam traps.

final-24-hour-revision.pdf (437.4 KB (447,917 bytes))
โฌ‡ Download PDF ๐Ÿ‘ Preview
๐Ÿ“‚ Complete Website Content Directory & How-To-Use Guide (Click to Expand) Directory & Instructions

How to Use This Platform

  1. Start with the OB/GYN Rescue Camp above (or jump directly to any module).
  2. Use ๐Ÿ“– Reading Mode on long clinical summary pages for a calm, centered textbook view.
  3. Complete 10-Question Progressive Sessions in Unsolved Practice Mode using the 3-level progressive hints.
  4. Take Mock Exams 1, 2 & 3 independently in Exam Mode and mark each mistake review completed.
  5. Download the 6 A4 PDFs from the PDF Library for offline study or printing.

Complete Page Directory

๐Ÿ“– Complete Master Compendium Reference (All 6 Original Sections On This Page) Full Source Compendium

1. Forensic Analysis of All 7 Uploaded Files & Verified Past Exam Patterns

To avoid wasting a single hour of your remaining 72 hours, we parsed every page of your 7 uploaded PDFs. Below is the verified breakdown of your source files, separating verified historical exam findings from strategic exam predictions.

Uploaded File Name Pages Verified Contents & Role in Your 72-Hour Rescue Strategy
Gynaecology Department Book 2025 (2).pdf 228 pp. Cairo University (Kasr Al Ainy) Essentials of Gynecology, 7th Edition (2025). Your status: Completed p.1โ€“100 (Anatomy, Endocrinology, Infertility, Contraception, Lower Genital Infections). Unfinished (p.100โ€“228): PID (p.100), Prolapse/Incontinence/Fistula (p.116), AUB/Fibroids/Endometriosis (p.137), and Gynecologic Oncology (p.164โ€“197).
Obstetric Department Book 2025 (2).pdf 182 pp. Cairo University (Kasr Al Ainy) Essentials of Obstetrics, 7th Edition (2025). Your status: Completed p.1โ€“100 (Physiology, ANC, Early Bleeding, APH, Medical Disorders, Rh, Normal Labor, Fetal Surveillance, OP/Face/Brow). Unfinished (p.100โ€“182): Breech/Transverse/Cord Prolapse/Twins (p.100), Abnormal/Obstructed Labor & Shoulder Dystocia (p.111), Uterine Rupture/Perineal Tears (p.119), PPH/Retained Placenta/Inversion/PROM/Preterm (p.124), Puerperium (p.153), and Forceps/Vacuum/CS (p.159).
ุงู“ุฎุฑ ูค ุงู…ุชุญุงู†ุงุช ู†ุณุง ูขู ูขูฆ.pdf 48 pp. Contains 4 actual 2026 exams (173 solved MCQs total):
โ€ข Exam 1 (p.1โ€“22): End Round B 2026 Gyna & Obs โ€” 69 MCQs (36 GYN / 33 OB).
โ€ข Exam 2 (p.23โ€“32): 2026 Combined Round Exam โ€” 44 MCQs (24 GYN / 20 OB; 34 of 44 questions are verbatim repeats from Exam 1!).
โ€ข Exam 3 (p.33โ€“40): OB/GYN Comprehensive Exam โ€” Section 1 (5 Short-Answer/Essay Qs) + Section 2 (30 MCQs, 93% Obstetrics).
โ€ข Exam 4 (p.41โ€“48): Final Gynecology Exam โ€” BSNU โ€” 30 MCQs (30 Marks, 100% Gynecology).
Final_Gynecology_BSNU_Solved_MCQs.pdf 8 pp. Standalone copy of Exam 4 above: Beni-Suef University (BSNU) Final Gynecology Exam (30 Solved MCQs with model explanations, 1 mark each).
ู…ู„ู ุงู„ู†ุณุง ุงู„ุดุงู…ู„ ูขู ูขูฆ ู…ุญู„ูˆู„-1.pdf 630 pp. Master Solved Bank containing Formatives 2022โ€“2025 (p.3โ€“68), End of Modules 2022โ€“2024 (p.69โ€“89), Finals 2022โ€“2024 (p.90โ€“93), Answered Formatives 2025 & Medad 52-Q Bank (p.94โ€“314), and 2026 Exams + Extended Topic Banks (p.315โ€“630).
mcqู†ุณุง.pdf 55 pp. Al-Dhayani (Jan 2026) OB/GYN Comprehensive Review MCQs: ~380 categorized recall & differentiation MCQs with Answer Key on p.52โ€“55. Several BSNU formative questions are drawn directly from this bank.
mcq-pathoู…ุญู„ูˆู„.pdf 14 pp. Scanned Pathology Department MCQ booklet (Female Genital System, Q809โ€“Q916, OCR-extracted). Extremely high-yield for histopathology & ovarian/uterine tumor markers (Psammoma bodies, Call-Exner bodies, Schiller-Duval bodies, Brenner urothelial metaplasia, Krukenberg signet-ring cells, CIN grading, Complete vs. Partial Mole).

Verified Exam Metrics vs. Strategic Predictions

Dimension Verified Finding from Uploaded Past Exams (2022โ€“2026) Strategic Prediction & Actionable Rule for Your Exam
Questions per Exam Single-subject Final Paper (OB or GYN separately): Exactly 30 MCQs (30 Marks), as seen in Final Gynecology BSNU (p.1โ€“8) and Exam 3 Section 2 (p.34โ€“40).
Combined End-of-Round / Module Exam: 44 to 69 MCQs (Exam 1 = 69 Qs; Exam 2 = 44 Qs).
Prepare stamina for up to 60โ€“70 MCQs in a combined sitting or 30 MCQs per paper if split into Paper 1 (Obstetrics) and Paper 2 (Gynecology) as listed in Comprehensive Bank p.3 (Finals 2023 & 2024).
OB vs. GYN Distribution In combined exams: 52% Gynecology / 48% Obstetrics (Exam 1: 36 GYN / 33 OB; Exam 2: 24 GYN / 20 OB). In split final papers: 100% OB (Paper 1) and 100% GYN (Paper 2). Split your study time 50% Gynecology / 50% Obstetrics, heavily weighted toward the unfinished p.100+ chapters in both books where Oncology, Abnormal Labor, PPH, and Operative Delivery reside.
Question Style & Difficulty ~35% Level 1โ€“2 (Direct Fact / EXCEPT / NOT True): e.g., "Absolute contraindication to COC", "Which is NOT a cause of vulval ulcers".
~50% Level 3 (Classic Clinical Vignette): 3โ€“5 sentence case leading to diagnosis, FIGO stage, or 1st-line management.
~15% Level 4 (Next-Best-Step / Contraindicated Maneuver Trap): e.g., Crohn's HMB refusing surgery โ†’ LNG-IUS; Shoulder dystocia โ†’ NO fundal pressure.
Over 35% of questions in 2026 exams are recycled word-for-word from Formatives 2022โ€“2025 and End Round B 2026. Mastering the exact wording of past exam stems guarantees rapid, automatic marks.

Top 15 Verbatim Repeated Concepts Across the 2026 Exams (Guaranteed Marks)

# Repeated Concept / Stem Verified Appearances in Uploaded Files Correct Exam Answer & Core Rule
1 Absolute contraindication to Combined Oral Contraceptive Pills (COCs) Exam 1 Q1 (p.1), Exam 2 Q5 (p.23), Final Gyn BSNU Q27 (p.7) Active liver disease (WHO MEC Category 4). Age <14 and asthma are NOT contraindications.
2 FIGO Staging of Endometrial Carcinoma (Stage IA vs IB vs II) Exam 1 Q2 (p.1), Exam 2 Q6 (p.24), Final Gyn BSNU Q1 (p.1) Stage IA: <50% myometrium; Stage IB: โ‰ฅ50% myometrium; Stage II: Cervical stromal invasion.
3 Heavy menstrual bleeding (HMB) + von Willebrand Disease (1st-line therapy) Exam 1 Q3 (p.2), Exam 2 Q7 (p.24), Comp Bank p.319 Combined oral contraceptive pills (COCs) (increase factor VIII/vWF and stabilize endometrium; NSAIDs are contraindicated in bleeding disorders!).
4 Labor progression: G2P1 at 40 wks dilating from 5 cm to 7 cm over 2 hours Exam 1 Q4 (p.2), Exam 2 Q8 (p.24), Comp Bank p.401 Normal labor (Active phase normal dilation rate is โ‰ฅ1 cm/hr in primigravida and โ‰ฅ1.2โ€“1.5 cm/hr in multipara; 2 cm in 2 hrs = 1 cm/hr).
5 Vaccination requiring 1-month pregnancy avoidance Exam 1 Q5 (p.2), Exam 2 Q9 (p.24), Comp Bank p.171 MMR (Measles, Mumps, Rubella) โ€” live attenuated viral vaccine.
6 Asymptomatic postmenopausal woman, 4.5 cm simple unilocular ovarian cyst, CA-125 = 10 IU/L Exam 1 Q13 (p.5), Exam 2 Q17 (p.26) Follow up with ultrasound in 4 months' time (Simple cyst <5 cm with normal CA-125 in postmenopause is managed conservatively).
7 Fetal presentation INCOMPATIBLE with spontaneous vaginal delivery Exam 1 Q22 (p.7โ€“8), Exam 2 Q26 (p.28), Exam 3 Q8 (p.35) Mentum posterior (Face presentation) โ€” fetal neck is already maximally extended and cannot extend further under the symphysis pubis; requires CS.
8 Shoulder dystocia management โ€” what is NOT done / contraindicated Exam 1 Q60 (p.19), Exam 2 Q36 (p.30), Exam 3 Q7 (p.35) Fundal pressure is strictly contraindicated (worsens impaction of anterior shoulder behind symphysis pubis, causes uterine rupture & Erb's palsy).
9 Antenatal corticosteroids in Prolonged Rupture of Membranes (PROM) Exam 1 Q69 (p.22), Exam 2 Q38 (p.31), Exam 3 Q17 (p.38) Reduces the incidence of neonatal Respiratory Distress Syndrome (RDS) (plus IVH and NEC).
10 High-dose Folic Acid (5 mg/day vs standard 0.4 mg/day) indication Exam 1 Q64 (p.20), Exam 2 Q37 (p.31) History of neural tube defect (spina bifida) in patient, partner, or prior pregnancy, or anti-epileptic drug use / pre-existing diabetes.
11 Ovarian tumor pathology markers: Psammoma vs Call-Exner vs Schiller-Duval vs Transitional cells Exam 1 Q37, Q39, Q40 (p.12โ€“13), Exam 2 Q33 (p.30), Patho MCQs Q861, Q870, Q874 Psammoma bodies: Serous cystadenocarcinoma; Call-Exner bodies: Granulosa cell tumor; Schiller-Duval bodies + AFP: Endodermal sinus (Yolk sac) tumor; Urothelial/Transitional cells: Brenner tumor.
12 Primary Amenorrhea with normal breasts (thelarche) & absent uterus: MRKH vs CAIS Exam 1 Q33 (p.11), Final Gyn BSNU Q4 (p.2) & Q20 (p.6), Comp Bank p.69 Differentiated by Serum Testosterone (or karyotype): MRKH = 46,XX, normal female testosterone, normal pubic hair; CAIS = 46,XY, male-range testosterone, absent/scanty pubic hair.
13 21-Hydroxylase Deficiency (Congenital Adrenal Hyperplasia - CAH) Exam 1 Q47 (p.15) & Q54 (p.17), Final Gyn BSNU Q12 (p.4) Most common cause of 46,XX ambiguous genitalia / simple virilizing CAH; screened via elevated 17-hydroxyprogesterone (17-OHP).
14 Indication for Abdominal Cerclage Exam 1 Q56 (p.18), Exam 2 Q35 (p.30) Failure of previous transvaginal cerclage (or congenital/surgical absence of vaginal cervix).
15 Anticoagulation in pregnant woman with Mechanical / Prosthetic Heart Valve Exam 1 Q25 (p.8โ€“9), Exam 3 Q29 (p.40), Comp Bank p.88 LMWH or Unfractionated Heparin (especially weeks 6โ€“12 and after 36 weeks; Warfarin crosses placenta causing fetal embryopathy/hemorrhage, and DOACs like Dabigatran are contraindicated).

2. Syllabus Prioritization Matrix (Priority A / B / C)

Because you have already studied the first 100 pages of both textbooks, your biggest vulnerability is pages 101โ€“228 of Gynecology and pages 101โ€“182 of Obstetrics. In the 2026 exams, 62% of all questions came from topics after page 100 (Gynecologic Oncology, AUB/Fibroids/Endometriosis, Prolapse/Fistula, PID, Abnormal Labor/Malpresentations, Shoulder Dystocia, PPH/Third Stage, and Forceps/Vacuum). At the same time, four chapters inside your first 100 pages (Amenorrhea/PCOS, Contraception, Early Pregnancy Bleeding, and APH/Preeclampsia) are tested on every single exam and must be reviewed via active recall.

Priority Tier Subject & Chapter Textbook Pages Your Current Status 2026 Exam Weight 72-Hour Strategic Action
PRIORITY A GYN Ch 9: Gynecologic Oncology (Endometrial, Cervical/CIN, Ovarian Tumors, Vulvar/VIN) Gyn p.164โ€“197 UNFINISHED (>p.100) Very High (~28% of GYN marks) Study First on Day 1 Morning. Memorize FIGO staging, CIN management, and Ovarian tumor histopathology bodies.
PRIORITY A GYN Ch 8: Benign Gyn Conditions (AUB, Fibroids, Endometriosis, Adenomyosis) Gyn p.137โ€“163 UNFINISHED (>p.100) High (~16% of GYN marks) Study Day 1 Morning. Focus on LNG-IUS vs COCs in AUB, Adenomyosis vs Fibroid, and Endometriosis laparoscopy/infertility.
PRIORITY A GYN Ch 2: Amenorrhea, DSD (MRKH, CAIS, Turner, CAH), PCOS & Hirsutism Gyn p.36โ€“65 Studied (โ‰คp.100) Very High (~22% of GYN marks) Rapid Consolidation Day 1 Afternoon. Do not re-read prose; drill diagnostic comparison tables and 2026 exam stems.
PRIORITY A GYN Ch 5 & Ch 3: Contraception & Infertility / OHSS Gyn p.66โ€“91 Studied (โ‰คp.100) High (~18% of GYN marks) Rapid Consolidation Day 1 Afternoon. Focus on COC contraindications, IUD mechanism, Emergency Contraception, Laparoscopy vs HSG, OHSS.
PRIORITY A GYN Ch 6 & Ch 7: PID, Vulvar Ulcers, Prolapse, Incontinence & Fistula Gyn p.100โ€“136 UNFINISHED (>p.100) High (~14% of GYN marks) Study Day 1 Evening. Focus on CDC PID criteria, DeLancey levels, Enterocele, Stress vs Urge Incontinence, VVF causes.
PRIORITY A OB Ch 9, 10, 11, 12, 16: Malpresentations, Abnormal Labor, Shoulder Dystocia, Perineal Tears & Forceps/Vacuum Obs p.96โ€“123, 159โ€“173 UNFINISHED (>p.100) Very High (~30% of OB marks) Study First on Day 2 Morning. Highest concentration of new OB marks: Mentum posterior, McRoberts, Vacuum vs Forceps, Perineal tear grades.
PRIORITY A OB Ch 13 & 15: Postpartum Hemorrhage (PPH), 3rd Stage, Uterine Inversion, PROM & Puerperal Pyrexia Obs p.124โ€“142, 153โ€“158 UNFINISHED (>p.100) High (~20% of OB marks) Study Day 2 Early Afternoon. Focus on 3rd stage signs of separation, PPH atony, Cord traction โ†’ Inversion, PROM steroids.
PRIORITY A OB Ch 3 & Ch 4: Early Pregnancy Bleeding (Abortion, Ectopic, Molar) & Antepartum Hemorrhage (Previa, Abruption, Accreta, Vasa Previa) Obs p.27โ€“50 Studied (โ‰คp.100) Very High (~24% of OB marks) Rapid Consolidation Day 2 Late Afternoon. Drill clinical differentiations (Previa vs Abruption; Complete vs Partial Mole; Ectopic MTX).
PRIORITY A OB Ch 5: Preeclampsia/Eclampsia, GDM, Cardiac Disease, Anticoagulation, Anemia & ICP Obs p.51โ€“69 Studied (โ‰คp.100) High (~20% of OB marks) Rapid Consolidation Day 2 Evening. Drill MgSO4 toxicity, GDM insulin & 6โ€“12 wk OGTT, Mitral stenosis, Mechanical valve LMWH, Bile acids/UDCA.
PRIORITY B OB Ch 1, 2, 6, 8, 14: Maternal Physiology, ANC/Folic Acid, Rh Isoimmunization, CTG Decelerations, Twins, Cephalohematoma Obs p.1โ€“26, 70โ€“72, 92โ€“95, 107โ€“110, 143โ€“152 Mixed (p.1โ€“95 done; p.107โ€“152 new) Moderate (~10% of marks) Targeted 90-Minute Sweep on Day 2 Night. Focus only on high-yield numbers: Folic acid 5 mg, Monochorionic TTTS, Cephalohematoma vs Caput, Late decelerations.
PRIORITY B GYN Ch 1, 2 (early), 11, 12, 13: Pelvic Blood Supply/Ureter Injury, Menstrual Physiology, HSG/Hysteroscopy/Uterine Perforation Gyn p.1โ€“35, 202โ€“215 Mixed (p.1โ€“35 done; p.202โ€“215 new) Moderate (~8% of marks) Targeted 60-Minute Sweep on Day 1 Night. Focus on Uterine artery origin (anterior division of internal iliac), Uterine perforation sign, Lower genital infections.
PRIORITY C GYN Ch 4, 10, 14 & OB Ch 17: Sexual Dysfunction, FGM, General History/Exam Checklists, Rare Medical Disorders (Epilepsy, Rare Embryology) Gyn p.76โ€“79, 198โ€“201, 216โ€“228; Obs p.174โ€“182 Skip unless extra time Very Low (<2% of marks) DO NOT STUDY TEXTBOOK PAGES. Only read if encountered inside a practice MCQ explanation.

3. Priority A High-Yield Summaries: Gynecology (G1โ€“G8)

Every Priority A topic below includes essential facts, classifications/numbers, diagnostic criteria, management guidelines, common MCQ traps from your 2026 exams, and a verified StatPearls/NCBI clinical reference link.

G1. Endometrial Hyperplasia, Endometrial Carcinoma & Uterine Sarcoma
Gyn Book p.164โ€“168 | Tested in Exam 1 Q2, Q17, Q63; Exam 2 Q6, Q21; Final Gyn Q1, Q2, Q11, Q29

Essential Facts & Classifications

  • Most common cause of Postmenopausal Bleeding (PMB) overall: Endometrial atrophy (60โ€“80%), while Endometrial carcinoma is the most lethal cause (~10% of PMB) and must be excluded first (Endometrial Cancer - StatPearls).
  • Type I (Endometrioid, 80%): Estrogen-dependent (obesity, PCOS/chronic anovulation, unopposed estrogen, Tamoxifen, late menopause, nulliparity, DM, HTN); PTEN mutation; preceded by atypical endometrial hyperplasia (EIN); favorable prognosis.
  • Type II (Papillary Serous & Clear Cell, 10โ€“20%): Estrogen-independent; arises in atrophic endometrium of older thin women; TP53 mutation; Papillary serous carcinoma is the most aggressive type with psammoma bodies and early extrauterine spread (Patho Q843).
  • FIGO Staging of Endometrial Cancer:
    โ€ข Stage IA: Confined to uterus, <50% myometrial invasion.
    โ€ข Stage IB: Confined to uterus, โ‰ฅ50% myometrial invasion (Final Gyn Q1).
    โ€ข Stage II: Invades cervical stroma (Exam 1 Q2).
    โ€ข Stage IIIA: Serosa / adnexa; IIIB: Vagina / parametrium; IIIC: Pelvic (IIIC1) or para-aortic (IIIC2) lymph nodes.
    โ€ข Stage IVA: Bladder/bowel mucosa; IVB: Distant metastases / inguinal nodes.

Diagnosis, Management & Distinctions

  • Diagnosis of PMB: Transvaginal Ultrasound (TVUS: endometrial thickness โ‰ค4 mm makes cancer unlikely) + Outpatient Endometrial Biopsy (Pipelle) or Hysteroscopy-guided biopsy (Gold standard for focal lesions; Final Gyn Q29).
  • Pyometra in postmenopausal women: Strongly suggests reproductive tract malignancy (endometrial or cervical cancer; Final Gyn Q11).
  • Endometrial Hyperplasia Management:
    โ€ข Without atypia: Progestogens (LNG-IUS is 1st-line or oral medroxyprogesterone acetate).
    โ€ข With nuclear atypia (EIN): Total Hysterectomy (high ~30% risk of coexisting/progressing to adenocarcinoma; Patho Q836).
  • Endometrial Cancer Treatment: Surgical staging via Total Abdominal Hysterectomy + Bilateral Salpingo-Oophorectomy (TAH + BSO) + pelvic/para-aortic lymphadenectomy. Compared to cervical cancer, endometrial cancer has a better prognosis and surgery (not radiotherapy) is the main line of treatment (Exam 1 Q17).
  • Uterine Sarcoma / Leiomyosarcoma: Most common symptom is abnormal uterine bleeding (Final Gyn Q2); differentiated histologically from benign leiomyoma primarily by the number of mitotic figures (>10 mitoses/10 HPF + coagulative necrosis; Patho Q844).
Common Exam Traps: (1) If the question asks for the most common cause of postmenopausal bleeding, choose Endometrial atrophy (Exam 1 Q63), NOT endometrial cancer! (2) Grade 2 tumor with >50% myometrial invasion is FIGO Stage IB (Final Gyn Q1), whereas extension into the cervix with negative nodes is Stage II (Exam 1 Q2).
G2. Cervical Intraepithelial Neoplasia (CIN), HPV & Cervical Cancer
Gyn Book p.169โ€“178 | Tested in Exam 1 Q7, Q12, Q17; Exam 2 Q10, Q15; Final Gyn Q21, Q22; Patho Q816, Q824โ€“826

Essential Facts & Classifications

  • Etiology & Site: Persistent infection with high-risk Human Papillomavirus (HPV 16 & 18) arising at the Transformation Zone (squamocolumnar junction) (Cervical Cancer - StatPearls).
  • Pathognomonic Viral Cytopathic Effect: Koilocytosis (perinuclear halo/vacuolization with nuclear enlargement and hyperchromasia; Patho Q816).
  • CIN Grading (depends on thickness of epithelium showing loss of maturation):
    โ€ข CIN 1 (LSIL): Dysplasia confined to lower 1/3 of epithelium (most regress spontaneously).
    โ€ข CIN 2 (HSIL): Lower 2/3 of epithelium.
    โ€ข CIN 3 (HSIL / CIS): >2/3 to full thickness, intact basement membrane.
  • HPV Vaccination: Standard textbook FDA approval tested in BSNU exams is girls and women aged 9 to 26 years (Exam 1 Q7, Final Gyn Q22); contraindicated in pregnancy.

Diagnosis, Staging & Management

  • Screening vs Definitive Diagnosis: Pap smear (exfoliative cytology) is a screening test. Abnormal Pap โ†’ Colposcopy with directed cervical punch biopsy (Gold standard for definitive diagnosis of CIN; Patho Q826).
  • Cervical Conization (LEEP / Cold-Knife Cone): Indicated for CIN 2/3, inadequate colposcopy, or Pap/biopsy discrepancy. INAPPROPRIATE / Contraindicated when deeply invasive cancer is already proven on biopsy (Exam 1 Q12).
  • Key FIGO Stages of Cervical Cancer:
    โ€ข Stage IA1: Stromal invasion โ‰ค3 mm depth; Stage IA2: >3 mm to โ‰ค5 mm.
    โ€ข Stage IB: Confined to cervix >5 mm depth; Stage IIA: Upper 2/3 vagina without parametrial invasion; Stage IIB: Parametrial invasion.
    โ€ข Stage IIIB: Pelvic sidewall extension and/or hydronephrosis / ureteric obstruction (most common cause of death is uremia).
    โ€ข Stage IVA: Bladder or rectal mucosa invasion (causes vesicovaginal fistula; Final Gyn Q28).
  • Invasive Cervical Cancer in Early Pregnancy (1st Trimester): Early stage disease can be treated promptly via radical hysterectomy in the first trimester (Final Gyn Q21).
Common Exam Traps: (1) Never choose conization if biopsy already shows frankly/deeply invasive cervical carcinoma (Exam 1 Q12). (2) Endocervical polyp is a benign inflammatory/hyperplastic lesion and is NOT a risk factor for cervical cancer (Patho Q823, Q892).
G3. Ovarian Cysts, Ovarian Torsion & Malignant Ovarian Tumors
Gyn Book p.159โ€“163, 182โ€“197 | Tested in Exam 1 Q13, Q23, Q37, Q39, Q40, Q61; Final Gyn Q18, Q25; Patho Q858โ€“878

Classification, Histopathology & Tumor Markers

  • 1. Epithelial Tumors (85โ€“90% of malignant ovarian tumors; peak age >50 yrs; marker = CA-125):
    โ€ข Serous Cystadenoma / Cystadenocarcinoma: Most common bilateral ovarian tumor; lined by tubal-like ciliated epithelium; contains concentric calcified Psammoma bodies (Exam 1 Q39; Patho Q874) (Epithelial Ovarian Cancer - StatPearls).
    โ€ข Mucinous Cystadenoma / Cystadenocarcinoma: Multilocular, huge size, endocervical/intestinal-like mucinous lining; rupture causes Pseudomyxoma peritonei (Patho Q860, Q862).
    โ€ข Brenner Tumor: Benign surface epithelial tumor with nests of transitional (urothelial) epithelium ("coffee-bean" nuclei; Exam 1 Q40; Patho Q861).
  • 2. Germ Cell Tumors (Most common in young women <20โ€“30 yrs; most common symptom = abdominal pain, Exam 1 Q23):
    โ€ข Mature Cystic Teratoma (Dermoid Cyst): Most common benign tumor in young women; contains hair, sebum, teeth, cartilage; high risk of ovarian torsion (Patho Q869, Q878) (Nonepithelial Ovarian Cancer - NCBI).
    โ€ข Struma Ovarii: Monodermal teratoma composed of thyroid tissue (causes hyperthyroidism; Patho Q868).
    โ€ข Dysgerminoma: Most common malignant germ cell tumor in young women & pregnancy; marker = LDH & placental ALP; exquisitely radiosensitive.
    โ€ข Endodermal Sinus (Yolk Sac) Tumor: Most aggressive germ cell tumor in children/young females; pathognomonic Schiller-Duval bodies (glomeruloid perivascular structures) and elevated Alpha-Fetoprotein (AFP) (Patho Q870, Q873).
  • 3. Sex Cord-Stromal Tumors:
    โ€ข Granulosa-Theca Cell Tumor: Secretes Estrogen โ†’ causes precocious pseudopuberty in young girls (Comp Bank p.114 Q26) or postmenopausal bleeding + endometrial hyperplasia/cancer in older women (Final Gyn Q25). Microscopic hallmark: Call-Exner bodies (Exam 1 Q37) + Inhibin marker.
    โ€ข Sertoli-Leydig Cell Tumor (Arrhenoblastoma): Secretes Testosterone / Androgens โ†’ rapid defeminization and virilization (hirsutism, clitoromegaly, deep voice; Exam 1 Q51; Patho Q866).
    โ€ข Fibroma / Meigs Syndrome: Benign ovarian fibroma + ascites + right hydrothorax (resolves after tumor removal).
  • 4. Metastatic: Krukenberg Tumor: Bilateral metastatic mucin-secreting signet-ring cell adenocarcinoma, most commonly from the stomach (pylorus) or colon (Patho Q875, Q916).

Management & Ovarian Torsion

  • Most Common Site of Metastasis from Ovarian Cancer: Peritoneum (transcoelomic seeding / omental cake; Exam 2 Q43).
  • Postmenopausal Simple Cyst Management: An asymptomatic postmenopausal woman with a simple, unilateral, unilocular ovarian cyst <5 cm (e.g., 4.5 cm) and normal CA-125 (<35 IU/L, e.g., 10 IU/L) is managed conservatively with repeat ultrasound follow-up in 4 months (Exam 1 Q13, Exam 2 Q17).
  • Ovarian Torsion:
    โ€ข Clinical Picture: Sudden-onset severe unilateral lower abdominal pain + nausea/vomiting + adnexal tenderness in a patient with a moderately sized mobile ovarian cyst (especially dermoid cyst, 5โ€“10 cm; endometriomas rarely twist because adhesions fix them!).
    โ€ข Ultrasound Sign: Enlarged edematous ovary, absent/decreased Doppler flow, and the pathognomonic "Whirlpool sign" of the twisted vascular pedicle (Exam 1 Q61, Final Gyn Q18).
    โ€ข Management: Emergency laparoscopy with detorsion and cystectomy (unless Frankly gangrenous/necrotic).
Common Exam Traps: (1) Do NOT operate immediately on an asymptomatic 4.5 cm simple cyst with CA-125 = 10 IU/L in a postmenopausal woman โ€” choose US follow-up in 4 months (Exam 1 Q13). (2) Do NOT confuse the 3 bodies: Psammoma = Serous; Call-Exner = Granulosa cell; Schiller-Duval = Endodermal sinus (Yolk sac) tumor.
G4. Amenorrhea, Disorders of Sex Development (DSD), PCOS & Hirsutism
Gyn Book p.36โ€“65 | Tested in Exam 1 Q24, Q31, Q33, Q34, Q36, Q45, Q47, Q51, Q54; Final Gyn Q4, Q6, Q9, Q12, Q17, Q19, Q20, Q23

Primary Amenorrhea & DSD Master Differential

  • Definitions: Primary amenorrhea = no menses by age 14 without secondary sexual characteristics, or by age 16 regardless of secondary sexual characteristics (Gyn Book p.45) (Primary Amenorrhea - StatPearls).
  • Normal Chronological Order of Puberty: Gonadarche โ†’ Thelarche โ†’ Pubarche โ†’ Menarche (Final Gyn Q19). Isolated breast budding <8 yrs with normal bone age is benign Premature Thelarche (Final Gyn Q23).
  • 1. Turner Syndrome (45,X0): Most common cause of primary amenorrhea overall (Exam 1 Q45). Absent breasts, uterus present (hypoplastic), streak ovaries (Exam 1 Q36), negative Barr body, elevated FSH/LH (hypergonadotropic hypogonadism), short stature, webbed neck, coarctation of aorta.
  • 2. MRKH Syndrome (Mรผllerian Agenesis, 46,XX): Normal ovaries โ†’ normal breasts + normal pubic/axillary hair, but absent/rudimentary uterus and blind-ending vagina (Final Gyn Q4). Normal female testosterone.
  • 3. Complete Androgen Insensitivity Syndrome (CAIS / Testicular Feminization, 46,XY): Androgen receptor defect โ†’ phenotypically female (NOT male! Exam 1 Q33) with normal breasts (aromatization of testosterone), absent uterus/upper vagina (AMH from testes still works), absent/scanty pubic & axillary hair, undescended testes. Differentiated from MRKH by Serum Testosterone (male range in CAIS vs female range in MRKH; Final Gyn Q20).
  • 4. Congenital Adrenal Hyperplasia (CAH): Most common cause of 46,XX ambiguous genitalia (clitoromegaly, fused labia; Exam 1 Q54) and simple virilizing precocious pubarche (Final Gyn Q12) is 21-Hydroxylase Deficiency. Screened via elevated 17-Hydroxyprogesterone (17-OHP) (Exam 1 Q47).

Secondary Amenorrhea, PCOS & Hirsutism

  • First Test in Any Woman with Amenorrhea (ยฑ Galactorrhea / Irregular Bleeding): Always perform a Serum ฮฒ-hCG (pregnancy test) FIRST (Exam 1 Q34) (Secondary Amenorrhea - StatPearls).
  • Causes of Secondary Amenorrhea: Pregnancy (most common), PCOS, Hyperprolactinemia, Premature Ovarian Insufficiency (associated with X-chromosome abnormalities; Final Gyn Q17), Asherman syndrome (intrauterine synechiae post-curettage presenting with hypomenorrhea / amenorrhea; Exam 2 Q23), and Sheehan syndrome (postpartum pituitary necrosis after severe PPH; failure of lactation; Cortisone/hydrocortisone replacement is the most critical initial therapy to prevent adrenal crisis before giving thyroxine; Final Gyn Q9). Note: Kallmann syndrome (anosmia + GnRH deficiency) causes primary, not secondary, amenorrhea (Comp Bank p.4 Q13).
  • PCOS (Rotterdam Criteria โ‰ฅ2 of 3): (1) Oligo/anovulation, (2) Clinical/biochemical hyperandrogenism, (3) Polycystic ovaries on US (โ‰ฅ12 follicles 2โ€“9 mm or volume >10 mL, "necklace" subcapsular cysts; Exam 1 Q24) (PCOS - StatPearls).
  • Hirsutism: Most common cause is PCOS (70โ€“80%) (Final Gyn Q6). Drug that causes hypertrichosis/hirsutism: Minoxidil (Exam 1 Q31; whereas Spironolactone, Ketoconazole, and Finasteride treat hirsutism). Finasteride side effect: decreased libido (Exam 1 Q8). Rapid-onset severe hirsutism + virilization (clitoromegaly, deep voice) = Androgen-secreting tumor (Exam 1 Q51).
Common Exam Traps: (1) In a 25-year-old with 8 weeks of amenorrhea and galactorrhea (Exam 1 Q34), do NOT pick Prolactin first โ€” pick hCG first to rule out pregnancy! (2) In Sheehan syndrome (Final Gyn Q9), always replace Cortisone first; giving thyroid hormone before glucocorticoids precipitates fatal adrenal crisis.
G5. Abnormal Uterine Bleeding (AUB), Leiomyomas, Adenomyosis & Endometriosis
Gyn Book p.137โ€“154 | Tested in Exam 1 Q3, Q14, Q21, Q38, Q55; Exam 2 Q7, Q32; Final Gyn Q8, Q13, Q30

AUB & Uterine Leiomyomas (Fibroids)

  • Heavy Menstrual Bleeding (HMB) Management Rules:
    โ€ข 1st-line medical therapy for chronic HMB with normal uterus (even if patient requests hysterectomy, e.g., multipara with Crohn's disease on sulfasalazine): Levonorgestrel-releasing Intrauterine System (LNG-IUS / Mirena) (Exam 1 Q38, Exam 2 Q32).
    โ€ข 1st-line therapy for HMB in adolescent/woman with von Willebrand Disease: Combined Oral Contraceptive Pills (COCs) (Exam 1 Q3; NSAIDs are contraindicated due to platelet inhibition!).
  • Premenstrual Syndrome (PMS) / PMDD: Most effective progestogen is Drospirenone (anti-mineralocorticoid & anti-androgenic 4th-gen progestin; Exam 1 Q14).
  • Uterine Leiomyomas (Fibroids):
    โ€ข Most common benign gynecologic tumor (firm, slowly growing uterine nodule; Final Gyn Q30) (Uterine Leiomyomata - StatPearls).
    โ€ข Most common clinical presentation overall: Asymptomatic (Exam 1 Q21). When symptomatic, submucosal fibroids cause heavy menstrual bleeding (menorrhagia).
    โ€ข Red (Carneous) Degeneration: Occurs during pregnancy (pain, low-grade fever, leukocytosis); managed conservatively with analgesics and rest (surgery in pregnancy causes massive hemorrhage).

Adenomyosis vs. Endometriosis

  • Adenomyosis: Presence of endometrial glands and stroma deep within the myometrium. Classic triad: multiparous woman in her 30sโ€“40s with menorrhagia + secondary dysmenorrhea + symmetrically enlarged, globular, soft/tender uterus (Final Gyn Q13).
  • Endometriosis: Presence of functioning endometrial glands and stroma outside the uterine cavity (Exam 1 Q55; Patho Q837) (Immunology at the Maternal-Fetal Interface - StatPearls).
    โ€ข Most common sites: Ovary ("Chocolate cyst" / endometrioma; Patho Q854) & Pouch of Douglas / uterosacral ligaments (nodules felt on PV exam).
    โ€ข Mechanism of Infertility: Multifactorial via pelvic adhesions, distorted tubo-ovarian anatomy, and chronic inflammatory cytokines that impair oocyte/embryo quality (Final Gyn Q8).
    โ€ข Gold Standard Diagnosis: Diagnostic Laparoscopy showing powder-burn / brown-black / red-blue serosal nodules with biopsy confirming endometrial glands & stroma (Exam 1 Q55).
Common Exam Traps: (1) Most common presentation of uterine fibroids is Asymptomatic (Exam 1 Q21), NOT metrorrhagia! (2) In Exam 1 Q38, even when the patient with HMB and normal uterus "requests a hysterectomy," the correct next step in guidelines is LNG-IUS.
G6. Contraception, Infertility & Ovarian Hyperstimulation Syndrome (OHSS)
Gyn Book p.66โ€“91 | Tested in Exam 1 Q1, Q9, Q10, Q11, Q18; Exam 2 Q5, Q12, Q13, Q14, Q22; Final Gyn Q3, Q7, Q16, Q27

Contraception High-Yield Exam Rules

  • Combined Oral Contraceptive Pills (COCs):
    โ€ข Absolute Contraindications (WHO Category 4): Active liver disease (Exam 1 Q1, Final Gyn Q27), current/history of VTE/PE, breast cancer, migraine with aura, smoking โ‰ฅ15 cig/day at age โ‰ฅ35, postpartum <6 weeks if breastfeeding.
    โ€ข Most common side effect of low-dose COCs: Breakthrough bleeding (Comp Bank p.6 Q3).
    โ€ข Drug decreasing COC efficacy (hepatic CYP450 enzyme inducer): Rifampicin (plus phenytoin, carbamazepine; Comp Bank p.6 Q4).
  • Barrier Contraception & Toxic Shock Syndrome (TSS): Associated with Cervical cap / Diaphragm / Sponge (Exam 1 Q10) (Contraception - StatPearls).
  • Intrauterine Contraceptive Device (Copper IUD): Primary mechanism is sterile inflammatory foreign-body reaction in the endometrium that is spermicidal / inhibits fertilization and implantation (NOT an abortifacient).
  • Emergency Contraception (EC): Includes Copper IUD (most effective, >99% up to 5 days) or oral Levonorgestrel / Ulipristal (most effective within 72โ€“120 hrs). False statement in Exam 1 Q11: "Oral EC pills reduce pregnancy rate by 99%" (oral pills reduce risk by ~75โ€“85%, whereas Copper IUD is 99%).

Infertility, Congenital Uterine Anomalies & OHSS

  • Definition of Infertility: Failure to conceive after 12 months of regular, unprotected intercourse in women <35 years (or 6 months if โ‰ฅ35 years; Final Gyn Q3) (Female Infertility - StatPearls).
  • Causes of Infertility: In BSNU Exam 1 Q9 / Exam 2 Q12, the keyed answer for most likely encountered female cause among listed options is Ovulatory dysfunction. Major cause of tubal occlusion/scarring is Pelvic Inflammatory Disease (PID) (Final Gyn Q7).
  • Tubal Evaluation: Screening test = HSG; Gold Standard = Diagnostic Laparoscopy with chromopertubation (Final Gyn Q16).
  • Recurrent Pregnancy Loss (RPL) Uterine Anomaly (Exam 1 Q62): Two distinct uterine horns/cavities with an external fundal indentation โ‰ฅ1 cm (e.g., 1.5 cm) = Bicornuate uterus (whereas a normal flat external fundus with internal septum = Septate uterus).
  • Ovarian Hyperstimulation Syndrome (OHSS): Complication of ovulation induction (Clomiphene/Gonadotropins + hCG trigger) driven by VEGF โ†’ third-spacing, ascites, hemoconcentration, thrombosis. Managed with fluid resuscitation, thromboprophylaxis, and paracentesis; Ovarian drilling is NOT used in OHSS management (Exam 1 Q18).
G7 & G8. Pelvic Organ Prolapse, Incontinence, Fistula, PID & Vulvar Pathology
Gyn Book p.92โ€“136 | Tested in Exam 1 Q20, Q27, Q35, Q66; Exam 2 Q24, Q30, Q42; Final Gyn Q5, Q10, Q14, Q15, Q26, Q28

Pelvic Floor Support, Prolapse, Incontinence & Fistula

  • DeLancey Levels of Vaginal Support:
    โ€ข Level I (Apical suspension of uterus & upper vagina): Cardinalโ€“Uterosacral ligament complex (Final Gyn Q5) (Pelvic Organ Prolapse - NCBI).
    โ€ข Level II (Mid-vaginal lateral attachment): Pubocervical & rectovaginal fascia to arcus tendineus.
    โ€ข Level III (Distal fusion): Perineal body & urogenital diaphragm.
  • Enterocele: The only true hernia among vaginal prolapses โ€” defined as protrusion of the pelvic peritoneal sac (Pouch of Douglas containing small bowel/omentum) and vaginal wall into the upper posterior vagina (Exam 1 Q20, Exam 2 Q24).
  • Stress Urinary Incontinence (SUI): Most common cause is childbirth trauma weakening the pelvic floor and urethral support (Final Gyn Q14).
  • Genitourinary Fistula: Vesicovaginal fistula (VVF) is the most common type; acquired causes (prolonged obstructed labor in developing countries; hysterectomy/surgical injury in developed practice) are the most common etiology, while congenital fistula is extremely rare (Final Gyn Q28).

PID, Vulvar Ulcers & Benign/Premalignant Vulvar Lesions

  • Pelvic Inflammatory Disease (PID): Minimum clinical diagnostic triad requires lower abdominal pain/tenderness + adnexal tenderness + cervical motion tenderness (excitation) (Final Gyn Q15).
  • Vulvar Ulcers Differential:
    โ€ข Painless, indurated (hard) ulcer (Chancre) + non-tender lymphadenopathy: Treponema pallidum (Syphilis) (Final Gyn Q10).
    โ€ข Painful soft ulcer: Haemophilus ducreyi (Chancroid) or HSV-2 (grouped vesicles).
    โ€ข NOT a cause of vulvar ulcers: Gonorrhea (Neisseria gonorrhoeae infects columnar epithelium causing endocervicitis/urethritis/Bartholin abscess, NOT vulvar squamous ulcers; Exam 1 Q35).
  • Vulvar Dermatology & VIN:
    โ€ข Lichen Sclerosus: Intense vulvar itching + thin white "cigarette-paper" plaques & figure-of-8 perianal ecchymosis (common in prepubertal girls, e.g., 7-year-old in Exam 1 Q66, and postmenopausal women). 1st-line treatment: Super-potent topical corticosteroid (Clobetasol propionate 0.05%) (Exam 1 Q66; do not mistake for sexual abuse!).
    โ€ข VIN (Vulvar Intraepithelial Neoplasia): Most common symptom is persistent pruritus vulvae (Exam 1 Q27).
    โ€ข Extramammary Paget Disease of Vulva: Red, crusted, eczematous lesion with intraepidermal vacuolated Paget cells; associated with an underlying or distant primary adenocarcinoma (breast, GI, genitourinary) in 15โ€“25% of cases (Exam 2 Q42; Patho Q815).

4. Priority A High-Yield Summaries: Obstetrics (O1โ€“O8)

O1. Normal & Abnormal Labor, Malpresentations & Shoulder Dystocia
Obs Book p.73โ€“118 | Tested in Exam 1 Q4, Q15, Q22, Q49, Q52, Q58, Q60, Q67; Exam 2 Q8, Q19, Q26, Q36; Exam 3 Q1, Q2, Q7, Q8, Q15, Q22, Q25, Q28

Stages & Mechanism of Normal Labor

  • Stages of Labor:
    โ€ข 1st Stage: From onset of true regular labor contractions to full cervical dilatation (10 cm) (Exam 1 Q67). Divided into Latent phase (0โ€“5 cm) and Active phase (โ‰ฅ5โ€“6 cm, normal rate โ‰ฅ1 cm/hr; thus 5 to 7 cm over 2 hours in Exam 1 Q4 is Normal labor) (Normal Labor - StatPearls).
    โ€ข 2nd Stage: Full cervical dilatation (10 cm) to delivery of the fetus.
    โ€ข 3rd Stage: Delivery of the fetus to delivery of the placenta (15โ€“30 min; duration of the 3rd stage in primigravida is equal to that in multipara; Exam 3 Q1).
  • Sequence of Mechanism of Normal Labor (OA): Descent โ†’ Engagement โ†’ Increased Flexion โ†’ Internal Rotation โ†’ Extension (delivery of head) โ†’ Restitution & External Rotation (Exam 3 Q25).
  • Active-Phase Labor Arrest (Exam 1 Q52): No cervical dilation change from 6 cm and no descent for โ‰ฅ4 hours despite strong/adequate contractions = Cephalopelvic Disproportion (CPD) โ†’ deliver by Cesarean section.

Malpresentations, Cord Prolapse & Shoulder Dystocia

  • Face Presentation: Characterized by hyperextension of the fetal head (Exam 3 Q2; denominator = Mentum).
    โ€ข Mentum Anterior: Can deliver vaginally by flexion.
    โ€ข Mentum Posterior: INCOMPATIBLE with spontaneous vaginal delivery (Exam 1 Q22, Exam 2 Q26) and is a classic cause of obstructed labor (Exam 3 Q8) โ†’ mandatory CS.
  • Umbilical Cord Prolapse: Descent of cord below presenting part after membrane rupture; more common with abnormal fetal lie (transverse/breech) (Exam 1 Q15); emergency CS if fetus is viable.
  • Shoulder Dystocia (Turtle Sign): Impaction of anterior fetal shoulder behind maternal symphysis pubis.
    โ€ข Allowed Maneuvers (HELPERR): Call for help, Episiotomy, McRoberts maneuver (hyperflexion/abduction of maternal thighs โ€” 1st-line), Suprapubic pressure, Woods corkscrew / Rubin maneuver, Delivery of posterior arm, Gaskin all-fours, Zavanelli maneuver (last resort).
    โ€ข STRICTLY CONTRAINDICATED: Fundal pressure (Exam 1 Q60, Exam 2 Q36, Exam 3 Q7; also contraindicated in prolonged 2nd stage, Exam 1 Q58).
Common Exam Traps: (1) Whenever Fundal pressure appears as an option in second-stage arrest or shoulder dystocia (Exam 1 Q58, Q60; Exam 3 Q7), it is ALWAYS the wrong/contraindicated action. (2) In Primigravida vs Multipara (Exam 3 Q1), cervical effacement precedes dilation in primigravida, whereas the duration of the 3rd stage is equal in both.
O2. Operative Delivery (Vacuum & Forceps), Perineal Tears & Birth Injuries
Obs Book p.119โ€“123, 150โ€“152, 164โ€“173 | Tested in Exam 1 Q41, Q42, Q48, Q68; Exam 2 Q41; Exam 3 Q14, Q26, Q28, Q30

Vacuum Extractor (Ventouse) vs. Obstetric Forceps

  • Mandatory Prerequisites for Both (Exam 3 Q26): Fully dilated cervix (10 cm), ruptured membranes, engaged head, known position, empty bladder, adequate pelvis/analgesia.
  • Vacuum Cup Application Site ("Flexion Point"): Over the sagittal suture 3 cm anterior to the posterior fontanelle (which equals 3 cm posterior to the anterior fontanelle) (Exam 1 Q48).
  • Contraindications to Vacuum Extraction: Preterm fetus <34 weeks (e.g., 31 weeks in Exam 1 Q41) due to risk of intraventricular/subgaleal hemorrhage, plus Face or Breech presentation.
  • Vacuum vs. Forceps Complications: Vacuum has higher fetal scalp trauma (Cephalohematoma, retinal hemorrhage; Exam 1 Q42) and higher failure rate, but less maternal soft-tissue trauma than forceps.

Perineal Tears, Episiotomy & Cephalohematoma

  • Perineal Tear Classification (Obs Book p.121):
    โ€ข 1st Degree: Fourchette, vaginal mucosa, and perineal skin only (muscles intact).
    โ€ข 2nd Degree: Perineal skin/mucosa + perineal body / transverse perineal muscles (but NOT anal sphincter; Exam 3 Q14). A 2nd-degree perineal tear is anatomically equivalent to a mediolateral episiotomy (Exam 1 Q68).
    โ€ข 3rd Degree: Involves anal sphincter complex (EAS/IAS).
    โ€ข 4th Degree: Extends through anal sphincter into ano-rectal mucosa.
  • Cephalohematoma vs. Caput Succedaneum (Exam 3 Q30):
    โ€ข Cephalohematoma: Subperiosteal hemorrhage (between periosteum and skull bone); does NOT cross suture lines; appears hours after birth, resolves over weeks; do NOT aspirate/drain (risk of infection).
    โ€ข Caput Succedaneum: Serosanguinous subcutaneous edema above periosteum; crosses suture lines; present at birth and disappears in 24โ€“48 hours.
O3. Postpartum Hemorrhage (PPH), Third Stage, Retained Placenta & Uterine Inversion
Obs Book p.124โ€“135 | Tested in Exam 2 Q39; Exam 3 Q1, Q6, Q9, Q18, Q19

Third Stage of Labor & Postpartum Hemorrhage (PPH)

  • Three Classic Signs of Placental Separation (Exam 3 Q9): (1) Sudden gush of blood, (2) Uterus changes from discoid to globular/firm and rises in abdomen, (3) Lengthening of the umbilical cord (suprapubic pressure does not retract cord).
  • Active Management of the 3rd Stage: (1) Prophylactic uterotonic (Oxytocin 10 IU IM/IV โ€” 1st line), (2) Controlled cord traction (Brandt-Andrews maneuver) only after signs of placental separation, (3) Uterine tone assessment. (Note: Routine manual exploration of the uterus is NOT part of normal 3rd-stage management; in Exam 3 Q18 key, check both C/D carefully).
  • Postpartum Hemorrhage (PPH): Blood loss โ‰ฅ500 mL after vaginal delivery or โ‰ฅ1000 mL after CS (Postpartum Hemorrhage - StatPearls).
    โ€ข Most Common Cause (80%): Uterine Atony (boggy, soft uterus; Uterine Atony - StatPearls).
    โ€ข Two Most Common Indications for Emergency Postpartum Hysterectomy: Placenta accreta spectrum (accreta/increta/percreta) and refractory Uterine atony (Exam 2 Q39, Exam 3 Q6).

Uterine Inversion, Retained Placenta & Uterine Rupture

  • Acute Uterine Inversion (Exam 3 Q19): Rare, life-threatening complication caused by premature cord traction + fundal pressure on an unseparated (especially fundal) placenta in a relaxed uterus. Presents with severe hemorrhage, mass in vagina/introitus, absence of uterine fundus on abdominal palpation, and neurogenic/vasovagal shock out of proportion to visible blood loss. Management: Immediate manual replacement (Johnson maneuver) + uterine relaxants (tocolytics/halogenated anesthetic), followed by uterotonics once replaced.
  • Retained Placenta: Failure to deliver placenta within 30 minutes of fetal delivery (Exam 3 Essay Q1; Comp Bank p.83). If separated and trapped โ†’ controlled traction; if unseparated โ†’ manual removal under anesthesia (unless Placenta Accreta Spectrum โ†’ Cesarean hysterectomy).
  • Uterine Rupture: Major complication of prolonged obstructed labor in multipara or TOLAC/VBAC with prior classical CS scar (Exam 3 Q28) (Uterine Rupture - StatPearls).
O4. Antepartum Hemorrhage (Placenta Previa, Abruption, Accreta & Vasa Previa)
Obs Book p.44โ€“50 | Tested in Exam 1 Q16; Exam 2 Q1, Q20, Q25; Exam 3 Q6, Q13, Q20

Placenta Previa vs. Placental Abruption (Abruptio Placentae)

  • Placenta Previa: Implantation of placenta in lower uterine segment (โ‰ฅ28 weeks) (Placenta Previa - StatPearls).
    โ€ข Clinical Hallmarks: Painless, causeless, recurrent bright-red vaginal bleeding (Exam 3 Q13); soft, non-tender uterus; high/unengaged presenting part or malpresentation; fetal heart rate usually normal initially; shock is proportional to visible blood loss (therefore "shock out of proportion to bleeding" is NOT true for placenta previa; Exam 2 Q25).
    โ€ข Absolute Rule: NEVER perform a digital vaginal (PV) examination until placenta previa is excluded by ultrasound.
    โ€ข Management of Central / Major Placenta Previa at 37 weeks: Elective Cesarean Section (Exam 1 Q16, Exam 2 Q20).
  • Placental Abruption (Accidental Hemorrhage): Premature separation of a normally situated placenta (Placental Abruption - StatPearls).
    โ€ข Strongest Risk Factors: Prior abruption, Maternal hypertension / Preeclampsia (Exam 3 Q20), trauma, smoking/cocaine, polyhydramnios sudden decompression.
    โ€ข Clinical Hallmarks: Sudden painful dark vaginal bleeding, tense/woody hard tender uterus, fetal distress/IUFD, shock out of proportion to visible bleeding (concealed retroplacental hemorrhage / Couvelaire uterus), and high risk of DIC.

Placenta Accreta Spectrum (PAS) & Vasa Previa

  • Placenta Accreta Spectrum (PAS): Abnormal adherence of chorionic villi directly to myometrium due to absent decidua basalis (defective Nitabuch's layer), strongly associated with Placenta Previa + Prior Cesarean Section(s).
    โ€ข Accreta: Attached to superficial myometrium; Increta: Invades into myometrium; Percreta: Penetrates through serosa into bladder.
    โ€ข Management: Planned Cesarean Hysterectomy (Exam 2 Q39, Exam 3 Q6).
  • Vasa Previa: Unprotected fetal umbilical vessels coursing through membranes over the internal os (velamentous cord insertion or bilobed/succenturiate placenta).
    โ€ข Verified Risk Factors (Exam 2 Q1): Bilobed placenta, IVF conception, multifetal gestation, low-lying placenta. (Photocoagulopathy is NOT a risk factor; Exam 2 Q1).
    โ€ข Presentation: Painless vaginal bleeding immediately upon rupture of membranes + sudden fetal bradycardia/exsanguination (confirmed by Apt test / Kleihauer-Betke test).
O5. Early Pregnancy Bleeding: Abortion, Ectopic Pregnancy & Molar Pregnancy (GTD)
Obs Book p.27โ€“43 | Tested in Exam 1 Q19, Q29, Q46, Q56, Q57; Exam 2 Q28, Q34, Q35; Exam 3 Q5, Q23, Q24; Patho Q846โ€“850

Abortion Types & Cervical Incompetence

  • Most Common Cause of Sporadic 1st-Trimester Miscarriage: Fetal chromosomal/genetic abnormalities (>50%, especially autosomal trisomies) (Exam 3 Q5).
  • Clinical Types of Abortion:
    โ€ข Threatened Abortion: Spotting + mild cramping + closed cervix + viable intrauterine fetus with cardiac pulsations on US (Exam 1 Q19).
    โ€ข Inevitable Abortion: Bleeding + cramping + dilated internal os / herniating membranes (Comp Bank p.5 Q50).
    โ€ข Missed Abortion / Blighted Ovum (Anembryonic Pregnancy): Closed cervix; gestational sac โ‰ฅ25 mm mean sac diameter on TVUS with no embryonic pole (Exam 1 Q57).
  • Cervical Incompetence: Painless 2nd-trimester cervical dilatation and membrane prolapse. Treated with transvaginal McDonald/Shirodkar cerclage at 12โ€“14 weeks. Indication for Abdominal Cerclage: Failure of a previous transvaginal cerclage (Exam 1 Q56, Exam 2 Q35).

Ectopic Pregnancy & Gestational Trophoblastic Disease (GTD)

  • Ectopic Pregnancy: Most common site is Fallopian tube (Ampulla > Isthmus); most deadly rupture is Cornual/Interstitial (Ectopic Pregnancy - StatPearls).
    โ€ข Diagnosis: Positive/high ฮฒ-hCG (>discriminatory zone 1500โ€“2000 mIU/mL) + empty uterus on TVUS + unilateral adnexal mass (Exam 3 Q23). Classic physical exam sign: Cervical motion tenderness (excitation) + fullness in cul-de-sac (Pouch of Douglas) (Exam 3 Q24).
    โ€ข Complications of Rupture: Hemoperitoneum, shoulder-tip pain, maternal collapse/shock; Hematuria is NOT a complication of ruptured ectopic (Exam 1 Q46, Exam 2 Q34).
    โ€ข Most Cost-Effective Medical Treatment (unruptured, stable, ฮฒ-hCG <5000, no fetal cardiac activity): Systemic Methotrexate (Exam 1 Q29, Exam 2 Q28).
  • Hydatidiform Mole (Complete vs. Partial): (Hydatidiform Mole - StatPearls)
    โ€ข Complete Mole: 46,XX (or XY) diploid, 100% paternal; diffuse hydropic villi + circumferential trophoblastic proliferation; NO fetal parts/RBCs; snowstorm US; theca-lutein cysts; very high ฮฒ-hCG; ~15โ€“20% GTN risk.
    โ€ข Partial Mole: 69,XXY / 69,XXX triploid (Comp Bank p.211 Q69); focal hydropic villi + fetal parts present; <5% GTN risk.
    โ€ข Choriocarcinoma: Malignant cytotrophoblast + syncytiotrophoblast with hemorrhage/necrosis and complete absence of chorionic villi / fibrous stroma (Patho Q850); metastasizes hematogenously to lungs ("cannonball") and vagina.
O6โ€“O8. Preeclampsia/Eclampsia, Medical Disorders (GDM, Cardiac, VTE, ICP, Anemia) & PROM/Twins
Obs Book p.51โ€“72, 107โ€“110, 136โ€“142 | Tested in Exam 1 Q25, Q26, Q28, Q30, Q43, Q44, Q50, Q53, Q59, Q64, Q65, Q69; Exam 3 Q3, Q10, Q17, Q20, Q27, Q29

Preeclampsia, Eclampsia & Magnesium Sulfate

  • Preeclampsia: New-onset BP โ‰ฅ140/90 mmHg after 20 weeks + proteinuria (โ‰ฅ300 mg/24h) or end-organ dysfunction (Preeclampsia - StatPearls). Severe features: BP โ‰ฅ160/110, platelets <100k, elevated liver enzymes (2x), pulmonary edema, visual/cerebral symptoms.
  • Drug of Choice to Prevent & Stop Eclamptic Seizures: Magnesium Sulfate (MgSO4) (Exam 1 Q53; Pritchard IM or Zuspan IV regimen).
    โ€ข MgSO4 Toxicity Monitoring: First sign of toxicity is loss of patellar deep tendon reflexes (at 8โ€“10 mEq/L), followed by respiratory depression (<12โ€“16 breaths/min), and cardiac arrest. Mandatory clinical monitoring: reflexes, respiratory rate, and urine output (โ‰ฅ30 mL/hr).
    โ€ข Antidote for MgSO4 Toxicity: 10% Calcium Gluconate (10 mL IV slowly).
  • Antihypertensives in Pregnancy: Safe = Labetalol, Nifedipine, Methyldopa, Hydralazine. Contraindicated = ACE inhibitors, ARBs.

GDM, Cardiac, Thrombophilia, ICP, Anemia, PROM & Twins

  • Gestational Diabetes Mellitus (GDM):
    โ€ข Most common fetal complication of uncontrolled maternal DM: Macrosomia (Exam 3 Q27; mediated by fetal hyperinsulinemia), whereas the most specific congenital anomaly of pregestational DM is Caudal regression syndrome (sacral agenesis) and most common is VSD/cardiac (Gestational Diabetes - StatPearls).
    โ€ข If diet & exercise fail to control GDM: Start Insulin (gold standard 1st-line pharmacotherapy; Exam 1 Q43).
    โ€ข Postpartum GDM Follow-up Screening: 75g 2-hour OGTT at 6โ€“12 weeks postpartum (Exam 1 Q50).
  • Cardiac Disease in Pregnancy:
    โ€ข WHO Class IV (Contraindicated in pregnancy): Severe pulmonary arterial hypertension / Eisenmenger syndrome (Exam 1 Q26).
    โ€ข Mitral Stenosis (most common rheumatic lesion): Highest risk of acute pulmonary edema / heart failure is late 3rd trimester, intrapartum, and immediate (1st day) postpartum due to autotransfusion and increased stroke volume/cardiac output (Exam 1 Q44; Book55 Q1).
    โ€ข Diagnostic sign of true valvular heart disease in pregnancy: Diastolic murmur (Exam 3 Q10; soft systolic ejection murmurs are physiologic in pregnancy).
    โ€ข Mechanical Heart Valve Anticoagulation: LMWH or Unfractionated Heparin (Exam 1 Q25, Exam 3 Q29).
  • Intrahepatic Cholestasis of Pregnancy (ICP): 3rd-trimester intense pruritus on palms and soles worse at night + elevated serum bile acids (no rash) โ†’ treat with Ursodeoxycholic acid (UDCA) + close fetal monitoring (Exam 1 Q59).
  • Anemia & Folic Acid: Iron deficiency anemia is the most common anemia in pregnancy, diagnosed when Hb <11 g/dL in 1st & 3rd trimesters (or <10.5 g/dL in 2nd trimester) (Exam 1 Q65). High-dose Folic Acid 5 mg/day is given for history of spina bifida/NTD (Exam 1 Q64).
  • PROM, Pyelonephritis, Puerperal Pyrexia & Twins:
    โ€ข Antenatal Steroids in PROM: Reduce neonatal RDS (Exam 1 Q69, Exam 3 Q17).
    โ€ข Acute Pyelonephritis: 3rd-trimester high spiking fever (102ยฐF), chills, flank/back pain, bacteriuria/pyuria (Exam 3 Q3).
    โ€ข Puerperal Pyrexia Trap (Exam 1 Q32): Defined as fever โ‰ฅ38ยฐC within the first 10โ€“14 days (excluding first 24 hrs), NOT "within 6 weeks" (which makes Option A the "non-related/incorrect" statement in Exam 1 Q32!).
    โ€ข Dichorionic Diamniotic (DCDA) Twins: Have risk for preeclampsia, FGR, and PPH, EXCEPT Twin-to-Twin Transfusion Syndrome (TTTS), which occurs exclusively in Monochorionic twins (Exam 1 Q30, Exam 2 Q29).

5. Realistic Hour-by-Hour 3-Day (72-Hour) Emergency Study Schedule

This schedule is engineered for maximum score conversion: 11.5 net study hours per day, 7.5 hours of protected sleep (memory consolidation and clinical reasoning collapse without sleep), meal/prayer breaks, and active MCQ testing built into every block.

DAY 1 (Hours 0โ€“24): Gynecology Unfinished High-Yield Blitz (p.100โ€“228) + Endocrinology/Contraception Consolidation

Time Window Duration Study Block & Exact Source Pages Execution Method & Deliverable Used
08:00 โ€“ 11:00 3.0 hrs Block 1A (NEW): Gynecologic Oncology โ€” Endometrial Cancer, Cervical Cancer/CIN, Ovarian Tumors, VIN/Paget (Gyn Book p.164โ€“197) Study Master Plan Summary Cards G1โ€“G3 + drill all Oncology questions in Progressive MCQ Bank (Levels 1โ€“4) and Pathology MCQs.
11:00 โ€“ 11:30 0.5 hr Break & Hydration Step away from screens; brief walk.
11:30 โ€“ 14:00 2.5 hrs Block 1B (NEW): Benign Gyn Conditions โ€” AUB, Fibroids, Adenomyosis, Endometriosis (Gyn Book p.137โ€“163) Study Summary Card G5 + focus on LNG-IUS vs COCs (vWD), Fibroid degeneration, Adenomyosis vs Endometriosis laparoscopy.
14:00 โ€“ 15:00 1.0 hr Lunch & Power Rest Full meal + 20-minute eyes-closed rest.
15:00 โ€“ 17:30 2.5 hrs Block 1C (NEW): PID, Vulvar Ulcers, Prolapse, Urinary Incontinence & Genitourinary Fistula (Gyn Book p.100โ€“136) Study Summary Cards G7โ€“G8 + DeLancey levels, Enterocele, SUI vs Detrusor overactivity, VVF, Syphilis vs Chancroid vs Gonorrhea.
17:30 โ€“ 18:00 0.5 hr Afternoon Break Coffee/tea + light stretch.
18:00 โ€“ 20:30 2.5 hrs Block 1D (CONSOLIDATION p.1โ€“100): Amenorrhea, DSD (Turner/MRKH/CAIS/CAH), PCOS, Hirsutism, Infertility & Contraception (Gyn Book p.24โ€“91) Study Summary Cards G4 & G6. Do NOT re-read textbook chapters โ€” go straight to diagnostic tables and active recall.
20:30 โ€“ 21:30 1.0 hr Dinner Break Relax and recharge before night MCQ drill.
21:30 โ€“ 23:30 2.0 hrs Block 1E (ACTIVE RECALL): Solve all Gynecology questions in Progressive MCQ Bank (Unsolved) + Mock Exam 3 (Final Gynecology Paper, 40 MCQs) Grade immediately using Solved Bank & Mock Exam Answer Key. Circle every missed trap.
23:30 โ€“ 07:30 8.0 hrs Protected Sleep Mandatory hippocampal consolidation of Day 1 Gynecology material.

DAY 2 (Hours 24โ€“48): Obstetrics Unfinished High-Yield Blitz (p.100โ€“182) + Haemorrhage/Medical Disorders Consolidation

Time Window Duration Study Block & Exact Source Pages Execution Method & Deliverable Used
08:00 โ€“ 11:00 3.0 hrs Block 2A (NEW): Malpresentations, Abnormal/Obstructed Labor, Shoulder Dystocia, Perineal Tears & Forceps/Vacuum (Obs Book p.96โ€“123, 159โ€“173) Study Summary Cards O1 & O2. Master Face (mentum posterior), Breech, Cord prolapse, Shoulder dystocia maneuvers, Vacuum vs Forceps, Cephalohematoma.
11:00 โ€“ 11:30 0.5 hr Morning Break Walk & hydrate.
11:30 โ€“ 14:00 2.5 hrs Block 2B (NEW): Postpartum Hemorrhage (PPH), 3rd Stage, Retained Placenta, Uterine Inversion, PROM, Preterm Labor & Puerperium (Obs Book p.124โ€“142, 153โ€“158) Study Summary Card O3 + PROM steroids, PPH atony vs accreta hysterectomy, Uterine inversion from premature cord traction.
14:00 โ€“ 15:00 1.0 hr Lunch & Power Rest Full meal + 20-minute rest.
15:00 โ€“ 17:30 2.5 hrs Block 2C (CONSOLIDATION p.27โ€“50): Early Pregnancy Bleeding (Abortion, Ectopic, Molar/GTD) & Antepartum Hemorrhage (Previa, Abruption, Accreta, Vasa Previa) Study Summary Cards O4 & O5. Focus on Previa vs Abruption table, Complete vs Partial Mole, Ectopic MTX vs Laparoscopy, Blighted ovum 25 mm.
17:30 โ€“ 18:00 0.5 hr Afternoon Break Light snack & stretch.
18:00 โ€“ 20:30 2.5 hrs Block 2D (CONSOLIDATION p.51โ€“72 + Priority B Sweep): Preeclampsia/MgSO4, GDM, Cardiac/Valves, ICP, Anemia, Folic Acid, Twins & Rh Study Summary Cards O6โ€“O8. Drill MgSO4 toxicity, GDM insulin & 6โ€“12 wk screening, Mitral stenosis, Mechanical valves, DCDA vs MCDA twins.
20:30 โ€“ 21:30 1.0 hr Dinner Break Unwind before night exam simulation.
21:30 โ€“ 23:30 2.0 hrs Block 2E (ACTIVE RECALL): Complete all Obstetrics questions in Progressive MCQ Bank (Unsolved) + Mock Exam 2 (Final Obstetrics Paper, 40 MCQs) Grade immediately and review explanations for every incorrect option.
23:30 โ€“ 07:30 8.0 hrs Protected Sleep Full night's sleep before Final-Day Revision.

DAY 3 (Hours 48โ€“72 โ€” Final 24-Hour Rescue Revision & Full Mock Simulation)

Time Window Duration Study Block & Deliverable Focus Execution Method
08:00 โ€“ 10:30 2.5 hrs Block 3A: Full Timed Simulation โ€” Mock Exam 1 (Combined End-Round 50 MCQs) + Re-test Missed Questions from Mock Exams 2 & 3 Take Mock Exam 1 Unsolved under strict exam conditions (60 mins), then spend 90 mins reviewing every explanation in Mock Exams Solved.
10:30 โ€“ 11:00 0.5 hr Break Hydrate & reset.
11:00 โ€“ 14:00 3.0 hrs Block 3B: Past Exam Verbatim Audit (Last 4 Exams 2026 & Final Gyn BSNU) Rapid-fire pass through all 173 questions of ุงู“ุฎุฑ ูค ุงู…ุชุญุงู†ุงุช ู†ุณุง ูขู ูขูฆ.pdf (covered in our Progressive Bank & Mock Exams) so you recognize every recycled stem in 5 seconds.
14:00 โ€“ 15:00 1.0 hr Lunch & Rest Nourishing meal + 20-minute nap.
15:00 โ€“ 18:00 3.0 hrs Block 3C: Final 24-Hour Rescue Revision Sheet โ€” Part 1 (Numbers, Cutoffs, FIGO Staging, Tumor Bodies & Diagnostic Criteria) Read Final_24Hour_Emergency_Revision_Sheet.md Sections 1โ€“4 aloud, testing yourself on every number and classification table.
18:00 โ€“ 18:30 0.5 hr Break Light walk.
18:30 โ€“ 21:00 2.5 hrs Block 3D: Final 24-Hour Rescue Revision Sheet โ€” Part 2 (Management Algorithms, Commonly Confused Pairs & Top 30 Trap Drills) Finish Sections 5โ€“8 of Final_24Hour_Emergency_Revision_Sheet.md. Do NOT open any new textbook chapters!
21:00 โ€“ 22:30 1.5 hrs Light Dinner & Final 30-Minute Flash Review of Your Personal Weak-Spot List Prepare exam ID/stationery; stop studying by 22:30.
22:30 โ€“ 06:30 8.0 hrs Pre-Exam Sleep Enter the exam hall rested, sharp, and locked onto exam traps.

6. Index of Your Complete 6-File Rescue Deliverable Suite

File # Deliverable Filename Contents & How to Use It
1 OBGYN_3Day_Emergency_Rescue_Master_Plan.html This Master Strategy Report: Exam Forensics, Priority A/B/C Syllabus Matrix, 16 Priority A Clinical Deep-Dive Summaries with NCBI StatPearls links, and the 72-Hour Schedule.
2 Progressive_MCQ_Rescue_Bank_SOLVED.md Version A (SOLVED): 80 high-yield progressive MCQs arranged across Level 1 (Recall), Level 2 (Differentiation), Level 3 (Clinical Vignettes), and Level 4 (Advanced Traps) with full answers, explanations, why distractors fail, source tags, and takeaways.
3 Progressive_MCQ_Rescue_Bank_UNSOLVED.md Version B (UNSOLVED): Exact same 80 progressive MCQs in identical order and numbering with zero answers or hints for active self-testing.
4 OBGYN_Mock_Exams_1_2_3_UNSOLVED.md 3 Full-Length Unsolved Mock Exams (130 MCQs total): Mock Exam 1 (Combined OB/GYN End-Round Style, 50 MCQs), Mock Exam 2 (Final Obstetrics Paper Style, 40 MCQs), and Mock Exam 3 (Final Gynecology Paper Style, 40 MCQs). Every question is explicitly tagged [ACTUAL PAST EXAM] or [NEW PATTERN-MATCHED].
5 OBGYN_Mock_Exams_1_2_3_SOLVED_and_Answer_Keys.md Separate Quick-Correction Answer Key Grids + Full Solved Explanations for all 130 questions across Mock Exams 1, 2, and 3.
6 Final_24Hour_Emergency_Revision_Sheet.md Last-Day 24-Hour Concentrated Rescue Package: High-yield numbers & cutoffs, FIGO staging tables, diagnostic criteria, management algorithms, commonly confused conditions, pathology bodies, and top exam traps.